Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
Status:
Completed
Trial end date:
2019-11-20
Target enrollment:
Participant gender:
Summary
The aim of this work is to study the value of GnRH antagonist subcutaneous administration as
an alternative to coasting in prevention of severe OHSS and its impact on embryos quality &
the outcome of ICSI.
Phase:
Phase 4
Details
Lead Sponsor:
ClinAmygate
Collaborators:
Al-Azhar University Beni-Suef University Cairo University